What we do

Omixon is a global biotechnology company that commercializes disruptive innovations specializing in targeted applications for Next Generation Sequencing (NGS). The Omixon Holotype HLA™ product combines a targeted HLA Assay and the Omixon HLA Twin™ software to deliver the most accurate high-resolution HLA genotyping available. Omixon maintains an active grant-funded research program and assists scientists and clinicians to analyze the most challenging genomic regions including HLA, KIR and ABO.


Omixon Blog

Omixon’s First “Learn Me” Video on the New Features of HLA Twin™

New Feature Highlights A new release of Omixon HLA Twin is now available. Major re-design has taken place to provide a simplified workspace while adding several new features and improvements. Top New Features in HLA Twin 1.1.2 Modified Dashboard similar to a …more

By kriszta.katona 0 comments

Meet Our New Director of Sales for the Americas

We are happy to introduce our new colleague, Faisal Mojaddidi, who’s originally from Afghanistan, and based in the US since an early age. Having a background in Psychology and Biology, Faisal is highly passionate about personalized medicine, and he will …more

By kriszta.katona 0 comments